InMed Pharmaceuticals Inc expected to post a loss of 35 cents a share - Earnings Preview

InMed Pharmaceuticals

09/11/2021 19:31

* InMed Pharmaceuticals Inc  INM.OQ   INM.O  is expected
to report results on November 11 (estimated).
* The Vancouver, British Columbia-based company is expected to
report revenue of $250 thousand, according to the estimate from
one analyst, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for InMed Pharmaceuticals
Inc is for a loss of 35 cents per share. 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for InMed
Pharmaceuticals Inc is $9​, about 83.1% above​ its last closing
price of $1.52. ​​​
This summary was machine generated November 9 at 19:31 GMT.  All
figures in US dollars  unless otherwise stated